TMobile US Inc TMUS Shifting Market Narrative Emerges Amid Mixed Analyst Price Target Adjustments And Catalyst Updates SLNO Soleno Therapeutics tops Q4 2025 EPS estimates by 103 percent shares edge 021 percent lower today NOM Nuveen latest quarterly earnings report carries no consensus comparable metrics as management reaffirms its muni portfolio strategy